Symbol="CFRX"
AssetType="Common Stock"
Name="ContraFect Corp"
Description="ContraFect Corporation, a clinical-stage biotechnology company, focuses on the discovery and development of protein and antibody therapeutics for the treatment of drug-resistant and life-threatening infectious diseases in the United States. The company is headquartered in Yonkers, New York."
CIK="1478069"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="PHARMACEUTICAL PREPARATIONS"
Address="28 WELLS AVENUE, 3RD FLOOR, YONKERS, NY, US"
FiscalYearEnd="December"
LatestQuarter="2023-06-30"
MarketCapitalization="7921600"
EBITDA="-37558000"
PERatio="None"
PEGRatio="0"
BookValue="-0.104"
DividendPerShare="0"
DividendYield="0"
EPS="-914.83"
RevenuePerShareTTM="0"
ProfitMargin="0"
OperatingMarginTTM="0"
ReturnOnAssetsTTM="-0.785"
ReturnOnEquityTTM="-6.09"
RevenueTTM="0"
GrossProfitTTM="-1606434"
DilutedEPSTTM="-914.83"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="0"
AnalystTargetPrice="5"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="-"
PriceToBookRatio="0.441"
EVToRevenue="-"
EVToEBITDA="0.163"
Beta="0.462"
num_52WeekHigh="20.41"
num_52WeekLow="0.69"
num_50DayMovingAverage="1.163"
num_200DayMovingAverage="3.915"
SharesOutstanding="10704800"
DividendDate="2020-02-04"
ExDividendDate="None"
symbol="CFRX"
open="0.75"
high="0.76"
low="0.72"
price="0.73"
volume="22245.00"
latest_trading_day="2023-08-31"
previous_close="0.74"
change="-0.01"
change_percent="-1.2162%"
aroon_positive_momentum_days="0"
aroon_negative_momentum_days="66"
trend_strength="Absent or Weak Trend"
buying_signal="Strong Sell Signal"
volume_analysis="Trending High"
value_analysis="Bullish Trend"
Aroon_change="FALSE"
Aroon_momentum="34"
Volume_recent_avg="2631233"
Change_recent_avg="-0.04"
Delta_recent_avg="0.18"
Variance_recent_avg="0.09"
Change_ratio_recent_avg="-2.74"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="negative"
Aroon_change="FALSE"
Aroon_momentum_positive="34"
Aroon_momentum_negative="66"
image_negative_thumbnail_id_1="165"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0011.jpeg"
image_negative_thumbnail_id_2="97"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0079.jpeg"
image_neutral_thumbnail_id_1="536"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0063.jpeg"
image_neutral_thumbnail_id_2="587"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0012.jpeg"
image_positive_thumbnail_id_1="968"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0130.jpeg"
image_positive_thumbnail_id_2="972"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0134.jpeg"
image_professor_thumbnail_id_1="1174"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0008.jpeg"
image_professor_thumbnail_id_2="1175"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0009.jpeg"
